COVID-19 Impact on US General Anesthesia Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2021-2027

The US General Anesthesia Drugs Market size is expected to grow at an annual average of 3% during 2021-2027. Rising cancer prevalence, rapid growth in the geriatric population, and increasing number of emergency surgeries are some of the key factors driving the growth of general anesthesia in the United States.

The following Segmentation are covered in this report:

By Route of Administration

• Inhalational
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
• Intravenous
  • Propofol
  • Benzodiazepines
  • Ketamine
  • Methohexital Sodium
  • Others (Etomidate, Fentanyl, Remifentanil)

By End User

• Hospitals
• Ambulatory Surgery Centers

Scope of the Report

The research study analyses the US General Anesthesia Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

• Market Overview and growth analysis
• Import and Export Overview
• Volume Analysis
• Current Market Trends and Future Outlook
• Market Opportunistic and Attractive Investment Segment

Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume